VICTORIA MERRELL: Open Payments
NPI 1073797395 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,320 in 65 payments from 9 companies in 2025. Trend: 2023 $1,079 · 2024 $3,924 · 2025 $3,320
Consulting: $1,740Food & beverage: $1,580
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $2,202 |
| GENZYME CORPORATION | 4 | $320 |
| ABBVIE INC. | 17 | $233 |
| Amgen Inc. | 11 | $203 |
| Lilly USA, LLC | 8 | $174 |
| Novartis Pharmaceuticals Corporation | 1 | $113 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: TREMFYA, KEVZARA, RINVOQ, COSENTYX, ENBREL, TALTZ, EVENITY, SKYRIZI.
Industry payments across CA — which companies pay providers there.
